Testing the Safety of the Anti-cancer Drug, Sn-117m-DTPA, for Advanced Cancers That Have Spread to Bones
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Conjupro Biotherapeutics, Inc.
Stanford University
Novartis
Novartis
Tomsk National Research Medical Center of the Russian Academy of Sciences
Kivu Bioscience Inc.
AstraZeneca
BeOne Medicines
ViroMissile, Inc.
Replimune Inc.
Myeloid Therapeutics
Tizona Therapeutics, Inc
Clasp Therapeutics, Inc.
Poseida Therapeutics, Inc.
Baylor College of Medicine
MacroGenics
Nanjing Sanhome Pharmaceutical, Co., Ltd.
Iambic Therapeutics, Inc
SystImmune Inc.
SN BioScience
Eli Lilly and Company
Oscotec Inc.
Orano Med LLC
Eli Lilly and Company
Sichuan Baili Pharmaceutical Co., Ltd.
Jacobio Pharmaceuticals Co., Ltd.
GlaxoSmithKline
Fate Therapeutics
NextCure, Inc.
Shanghai Juncell Therapeutics
AbbVie
Second Affiliated Hospital, School of Medicine, Zhejiang University
Abramson Cancer Center at Penn Medicine
Daiichi Sankyo
AstraZeneca
SystImmune Inc.
Actym Therapeutics, Inc.
Taiho Oncology, Inc.
Olema Pharmaceuticals, Inc.
Sanofi
MediLink Therapeutics (Suzhou) Co., Ltd.
GONGCHU Biotechnology Co., Ltd
Novartis
Jonsson Comprehensive Cancer Center
First Affiliated Hospital of Zhejiang University
Sichuan Enray Pharmaceutical Sciences Company
Novita Pharmaceuticals, Inc.